CADTH has posted its Guidelines for Manufacturers on Application Fees for the CADTH pan-Canadian Oncology Drug Review on its website, after stakeholder comments and feedback were received last month.

Key changes made in response to stakeholders’ comments are detailed in CADTH’s April 1, 2015 notice of implementation.

For more information please see the complete Guidelines for Manufacturers on Application Fees for the pan-Canadian Oncology Drug Review or visit the CADTH website.